Multidisciplinary intensive outpatient rehabilitation program for patients with advanced Parkinson’s disease: feasibility and primary proof of concept
Objective: To describe as a proof of concept our experience with a multidisciplinary, intensive out-patient rehabilitation program (MIOR) for advanced PD patients. Background: Intensive, multi-dimensional…In-patient Parkinson courses and caregiver burden
Objective: To find out whether a 10 to 14 days group-based in-patient rehabilitation course for patients with Parkinson disease and their caregivers has any long-term…The Pull Test in healthy subjects and Parkinson´s disease: quantitative pull-force measure, postugraphic and electromyographic analysis
Objective: To study and compare in healthy subjects and patients with Parkinson´s disease (PD) the destabilizing force needed to reach the limit of stability (LoS), the displacements of…Immunomodulatory therapy in stiff-person syndrome (SPS): a controlled Rituximab-randomised study
Objective: -the efficacy of the anti-CD20 antibody, Rituximab, in the treatment of patients with Stiff-person syndrome Background: SPS is a rare autoimmune progressive disorder of…Characterization of Pisa syndrome in Parkinson’s disease.
Objective: This study has two main objectives. The first objective is to elucidate the effects of distraction and alteration of sensorimotor inputs (visual and proprioceptive…Elevated GM3 Plasma Concentration in Idiopathic Parkinson’s Disease: a Lipidomics Analysis
Objective: To test the association between plasma lipids and Parkinson disease (PD) diagnosis. Background: PD is a common neurodegenerative disease whose pathological hallmark is the…Development of a Clinical Outcomes Assessment (COA) in Pantothenate-Kinase Associated Neurodegeneration (PKAN): Item Generation and Clinimetric Properties
Objective: To develop a clinical outcome assessment (COA) scale that measures key aspects of functioning and daily living in patients with pantothenate kinase-associated neurodegeneration (PKAN)…The management of Parkinson’s disease in the Middle East countries: the MDS-middle east task force survey
Objective: The movement disorders society task force for the Middle East (MDS-Task Force for the Middle East) conducted a survey with an aim of characterizing…Evaluating the Experience of Diagnosis in Parkinson’s Disease
Objective: To evaluate a newly-designed diagnosis patient pathway for Parkinson’s disease, in terms of quality measures and patient satisfaction. Background: Receiving a diagnosis of Parkinson’s…Developing a guide to facilitate involving people with Parkinson’s and their carers in service improvement
Objective: To develop an easy-to-use guide for service development project leads and patients/carers to facilitate the involvement of the latter in the development and implementation…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.